Addex Therapeutics Ltd. (ADXN) insider trading.
In Q3 2026, insiders at Addex Therapeutics Ltd. reported 14 non-derivative transactions on 8 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 14
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 7
- Last filed
- 2026-09-04
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Dyer Timothy Mark | Director, Officer · CHIEF EXECUTIVE OFFICER | 2 | 0 | 0 |
| Hill Raymond George | Director | 2 | 0 | 0 |
| Lawton Vincent Michael | Director | 2 | 0 | 0 |
| Manke Isaac | Director | 2 | 0 | 0 |
| Mills Roger | Director, Officer · CHIEF MEDICAL OFFICER | 2 | 0 | 0 |
| Nunn Jason Raleigh | Director | 2 | 0 | 0 |
| Kalinichev Mikhail | Officer · HEAD OF TRANSLATIONAL SCIENCE | 2 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-02 | Dyer Timothy Mark | A (A) | 16,413,787 | $0 | 16,848,979 | Form 4 |
| 2026-09-02 | Dyer Timothy Mark | D (D) | 16,413,787 | $0 | 435,192 | Form 4 |
| 2026-09-02 | Hill Raymond George | A (A) | 1,365,532 | $0 | 1,365,532 | Form 4 |
| 2026-09-02 | Hill Raymond George | D (D) | 1,365,532 | $0 | 0 | Form 4 |
| 2026-09-02 | Lawton Vincent Michael | D (D) | 2,507,487 | $0 | 500 | Form 4 |
| 2026-09-02 | Lawton Vincent Michael | A (A) | 2,507,487 | $0 | 2,507,987 | Form 4 |
| 2026-09-02 | Manke Isaac | D (D) | 219,561 | $0 | 0 | Form 4 |
| 2026-09-02 | Manke Isaac | A (A) | 219,561 | $0 | 219,561 | Form 4 |
| 2026-09-02 | Mills Roger | D (D) | 392,837 | $0 | 393,139 | Form 4 |
| 2026-09-02 | Mills Roger | A (A) | 392,837 | $0 | 785,976 | Form 4 |
| 2026-09-02 | Nunn Jason Raleigh | D (D) | 219,561 | $0 | 0 | Form 4 |
| 2026-09-02 | Nunn Jason Raleigh | A (A) | 219,561 | $0 | 219,561 | Form 4 |
| 2026-09-02 | Kalinichev Mikhail | A (A) | 306,765 | $0 | 306,765 | Form 4 |
| 2026-09-02 | Kalinichev Mikhail | D (D) | 306,765 | $0 | 0 | Form 4 |
Transaction codes in this quarter
Get ADXN insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1574232&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · ADXN company page · Addex Therapeutics Ltd. on SEC.gov
Questions
Are insiders buying or selling Addex Therapeutics Ltd. (ADXN)?
In Q3 2026, insiders at Addex Therapeutics Ltd. reported 14 non-derivative transactions on 8 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Addex Therapeutics Ltd. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/adxn.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.